A new clinical study showed that cannabidiol, a common compound found in cannabis, could help reduce seizures in epilepsy patents by more than 40 percent. The 14 weeks treatment proved very beneficial both in adults and children suffering from severe epilepsy known as LGS.
COFFEE BREAK NEWS FOR LIFE SCIENTISTS
Researchers at Harvard University developed an effective personalized cancer vaccine that seems to have prevented early tumour relapse in 12 skin cancer patients. The vaccine targeted 20 tumour-specific proteins unique to each of the patients enrolled, keeping all free of cancer over 2 years after the trial.
A group of US researchers proposed a cutting edge alternative for eliminating resilient bacteria in the form of a “CRISPR pill”. The drug can specifically target harmful bugs using a combination of bacteria-seeking viruses and a cocktail of probiotics, making it more potent than most antibiotics.
Researchers at the University of Leuven (KU Leuven) have discovered that stevia stimulates a protein that is essential for our perception of taste and is involved in the release of insulin after a meal. These results create new possibilities for the treatment of diabetes.
Canadian researchers discovered that components of maple syrup may boost the antimicrobial effects of antibiotics by as much as 90% when used in combination. This synergy could provide an effective solution for the alarming threat of multi-drug resistant bacteria.
An international consortium of scientists have found a way to produce a semi-synthetic strain of baker´s yeast with more than a third of its chromosomes artificially synthesized.
US scientists have managed to transform spinach leaves into functional beating heart tissues with their own vascular networks, possibly opening up a new branch of tissue engineering science based on plant mimicry.
US scientists discovered a surprising hidden function of mammalian lungs – they help produce blood. Their study on mice showed that more than half of all platelets in mice are produced by the lungs, a process long attributed to bone marrow.
A new breast cancer drug combination significantly shrunk and eliminated tumours in 28% of women tested in just 11 days. The novel treatment involves a combination of pre-chemotherapy drugs lapatinib and trastuzumab that target HER2-positive tumours.
A pilot study set to uncover the potential of reversing type II diabetes resulted in remission of the disease in 40% of the patients taking part. The treatment involved a combination of intensive lifestyle interventions, oral medication, and insulin therapy.